Effect of tamoxifen on the receptor-positive T61 and the receptor-negative T60 human breast carcinomas grown in nude mice-Reference-Cited by-同舟云学术

Effect of tamoxifen on the receptor-positive T61 and the receptor-negative T60 human breast carcinomas grown in nude mice

Published:1985-11 Issue:11 Volume:21 Page:1349-1354
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Brünner Nils,Spang-Thomsen Mogens,Vindeløv Lars,Wolff Jacob,Engelholm Svend Aage

Publisher

Elsevier BV

Subject

Oncology

Reference24 articles.

1. Changes in X-ray sensitivity of Hela cells during the division cycle;Terasima;Nature,1961

2. Proliferation kinetics of a human breast cancer line in vitro following treatment with 17β-estradiol and 1-β-d-arabinofuranosylcytosine;Weichselbaum;Cancer Res,1978

3. Treatment of primary breast cancer with chemotherapy and tamoxifen;Fisher;N Engl J Med,1981

4. Summary of world data on “Nolvadex” (tamoxifen);Mouridsen;Rev Endocr Rel Cancer,1979

5. CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women: an EORTC study;Engelsman;Rev Endocr Rel Cancer,1981

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Some methods and applications of flow cytometric DNA analysis in clinical and experimental oncology;European Journal of Haematology;2009-04-24

2. A New Therapeutic Strategy against Hormone-Dependent Breast Cancer: The Preclinical Development of a Dual Aromatase and Sulfatase Inhibitor;Clinical Cancer Research;2008-10-15

3. The Use of Steroid Sulfatase Inhibitors as a Novel Therapeutic Strategy Against Hormone-Dependent Endometrial Cancer;Endocrinology;2008-05-01

4. Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer;Breast Cancer Research and Treatment;2007-10-04

5. In vivo Efficacy of STX213, A Second-Generation Steroid Sulfatase Inhibitor, for Hormone-Dependent Breast Cancer Therapy;Clinical Cancer Research;2006-09-15